About Dispatch Bio
On a mission to help create a world where all cancer patients can be cured
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Founded
- 2022
- Company type
- Privately Held
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
On LinkedIn
- Followers
- 7,402
- People linked to this company
- 66
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.